Gil M. Labrucherie, SVP, COO & CFO at NEKTAR THERAPEUTICS (NKTR), sold 14,490 shares at $19.67 ($285K) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Seasonal sale ($285k) by SVP, COO & CFO — this insider has traded NKTR in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.67 | 6,245 | $123K | 43.1% |
| 2 | $19.67 | 6,245 | $123K | 43.1% |
| 3 | $19.68 | 2,000 | $39K | 13.8% |
| Total | $19.67 avg | 14,490 | $285K | 100% |
| Filing → |
| NKTR | SELL | 2022-05-17 | $138K | — | Filing → |
| RZLT | BUY | 2022-05-09 | $400K | — | Filing → |
| NKTR | SELL | 2022-02-18 | $166K | — | Filing → |